Metabolic Syndrome Prevalence, Dietary Intake, and Cardiovascular Risk Profile Among Overweight and Obese Adults 18–50 Years Old From the United Arab Emirates

Al-Sarraj, Taif; Saadi, Hanane; Volek, R.D. Jeff S.; Fernández, María Luz

doi:10.1089/met.2009.0035

Cited by 30 publications

(29 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The prevalence of MS increased from normal weight (8.3%) to overweight (18.8%) to obesity (28.8%) in our study suggesting that these traders were at increased risk of developing CVD. This observation is similar to study among Emirati overweight and obese adults with 40% prevalence of metabolic syndrome [2]. Studies have reported the absence of metabolic abnormalities in some obese individuals with excess body fat [24,25].…”

Section: Discussionsupporting

confidence: 91%

“…MS predisposes individuals to increased risk for developing DM2 and CVD [2]. The prevalence of MS in traders in our study was 16.3%.…”

Section: Discussionmentioning

confidence: 44%

“… Obesity is epidemic worldwide as a result of physical inactivity and adoption of poor nutritional habits [1,2]. Obesity particularly its abdominal (visceral) component and insulin resistance are important twin components of metabolic syndrome (MS).…”

Section: Introductionmentioning

confidence: 99%

“…Visceral adiposity has been reported as the most common cause of insulin resistance and a powerful aetiopathogenic factor for the development of type 2 diabetes mellitus (DM2) and accelerated atherogenesis [3]. MS is the concurrence of disturbed glucose and insulin metabolism, overweight and abdominal fat distribution, mild dyslipidaemia, and hypertension associated with subsequent development of DM2 and cardiovascular disease (CVD) [2,4,5]. The prevalence of metabolic syndrome has been reported globally and is thought to affect Nigerians [2,[6][7][8][9].…”

Section: Introductionmentioning

confidence: 99%

“…MS is the concurrence of disturbed glucose and insulin metabolism, overweight and abdominal fat distribution, mild dyslipidaemia, and hypertension associated with subsequent development of DM2 and cardiovascular disease (CVD) [2,4,5]. The prevalence of metabolic syndrome has been reported globally and is thought to affect Nigerians [2,[6][7][8][9]. International Diabetes Federation (IDF) defined MS as waist circumference (WC) (> 90 cm for men; > 80 cm, women), triglycerides (TG) (> 150 mg/dL), high density lipoprotein cholesterol (HDL-C) (<40 mg/dL (men), < 45 mg/dL (women), blood pressure (BP) (> 135/80 mmHg), and fasting glucose (FG) (> 100 mg/dL) [7].…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Indices of Metabolic Syndrome in 534 Apparently Healthy Nigerian Traders

Charles-Davies¹,

Arinola²,

Fasanmade³

et al. 2012

UCMS

View full text Add to dashboard Cite

Background: Metabolic Syndrome (MS) increases the risk of developing type-2 diabetes (DM2) and cardiovascular diseases (CVD) and it is thought to be prevalent in Nigeria. This study aims at determining the prevalence of MS and its component risk factors among apparently healthy traders in a local market in Ibadan, Nigeria. Methods: 534 apparently healthy traders from a local market in Bodija, Ibadan, Nigeria aged (18-105) years with neither DM2 nor CVD were participants of a cohort study on risk assessment of type 2 diabetes and dementia in Nigerians with metabolic syndrome. The International Diabetes Federation (2005) and the World Health Organisation (1998) criteria were used for MS and BMI respectively. Anthropometric indices (weight, height, body mass index (BMI), percentage body fat (PBF), waist and hip circumferences (WC & HC) and their ratio (WHR), waist circumference to height ratio (WHT)) and blood pressure (BP) were obtained by standard methods. Blood samples (6 ml) were obtained for the determination of glucose (FPG), total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (HDL-C) by enzymatic methods while low density lipoprotein cholesterol (LDL-C) was calculated. Descriptive statistics, Chi-square test and ANOVA were among the analyses conducted. Results: 301 (56.4%) of traders studied were overweight (176, 33.0%) or obese (125, 23.4%) while 17 (3.4%) and 125 (40.4%) were underweight and normal weight respectively. The prevalence of MS and obesity were 87 (16.3%) and 125 (23.4%) respectively. There was significant association between obesity and MS (p < 0.05). Both MS and obesity were significantly associated with gender (p < 0.05). The prevalence of MS and obesity was higher in female (20.9%; 31.0%) than male traders (6.5%; 7.1%) respectively. The prevalence of MS increased from normal weight (8.3%) to overweight (18.8%) to obesity (28.8%). There were significantly higher differences in age, BP(systolic and diastolic), weight, BMI, WC, HC, WHT, WHR, and PBF but lower difference in height when overweight/obese groups were compared with normal weight group (p < 0.05). TC and LDL-C were significantly higher in only obese than normal weight traders. However, FPG, TG and HDL-C were similar in all groups (p > 0.05). Conclusion: There is high prevalence of MS and obesity among Nigerian traders. Female gender, hypercholesterolemia, hypertension, increasing age, general and abdominal obesity appear to be important metabolic risk factors of CVD and not DM2 among Nigerian traders. Health care strategies for effective modulation of diet and lifestyle are needed urgently. In addition, screening programs for indices of MS in all Nigerians irrespective of BMI could be considered.

show abstract

Section: Discussionsupporting

confidence: 91%

“…MS predisposes individuals to increased risk for developing DM2 and CVD [2]. The prevalence of MS in traders in our study was 16.3%.…”

Section: Discussionmentioning

confidence: 44%

Section: Introductionmentioning

confidence: 99%